rs77893539
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_030928.4(CDT1):c.1581G>A(p.Ala527Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00138 in 1,610,794 control chromosomes in the GnomAD database, including 12 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0056 ( 8 hom., cov: 34)
Exomes 𝑓: 0.00094 ( 4 hom. )
Consequence
CDT1
NM_030928.4 synonymous
NM_030928.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.87
Publications
1 publications found
Genes affected
CDT1 (HGNC:24576): (chromatin licensing and DNA replication factor 1) The protein encoded by this gene is involved in the formation of the pre-replication complex that is necessary for DNA replication. The encoded protein can bind geminin, which prevents replication and may function to prevent this protein from initiating replication at inappropriate origins. Phosphorylation of this protein by cyclin A-dependent kinases results in degradation of the protein. [provided by RefSeq, Mar 2011]
CDT1 Gene-Disease associations (from GenCC):
- Meier-Gorlin syndrome 4Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P
- Meier-Gorlin syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.71).
BP6
Variant 16-88808218-G-A is Benign according to our data. Variant chr16-88808218-G-A is described in ClinVar as Benign. ClinVar VariationId is 128672.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.87 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00563 (858/152368) while in subpopulation AFR AF = 0.0192 (799/41592). AF 95% confidence interval is 0.0181. There are 8 homozygotes in GnomAd4. There are 412 alleles in the male GnomAd4 subpopulation. Median coverage is 34. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 8 AD,AR gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CDT1 | NM_030928.4 | c.1581G>A | p.Ala527Ala | synonymous_variant | Exon 10 of 10 | ENST00000301019.9 | NP_112190.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CDT1 | ENST00000301019.9 | c.1581G>A | p.Ala527Ala | synonymous_variant | Exon 10 of 10 | 1 | NM_030928.4 | ENSP00000301019.4 |
Frequencies
GnomAD3 genomes AF: 0.00562 AC: 856AN: 152250Hom.: 8 Cov.: 34 show subpopulations
GnomAD3 genomes
AF:
AC:
856
AN:
152250
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00147 AC: 356AN: 242676 AF XY: 0.00104 show subpopulations
GnomAD2 exomes
AF:
AC:
356
AN:
242676
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000941 AC: 1372AN: 1458426Hom.: 4 Cov.: 31 AF XY: 0.000818 AC XY: 593AN XY: 725300 show subpopulations
GnomAD4 exome
AF:
AC:
1372
AN:
1458426
Hom.:
Cov.:
31
AF XY:
AC XY:
593
AN XY:
725300
show subpopulations
African (AFR)
AF:
AC:
779
AN:
33452
American (AMR)
AF:
AC:
42
AN:
44368
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
25996
East Asian (EAS)
AF:
AC:
0
AN:
39650
South Asian (SAS)
AF:
AC:
4
AN:
85778
European-Finnish (FIN)
AF:
AC:
0
AN:
52024
Middle Eastern (MID)
AF:
AC:
3
AN:
5764
European-Non Finnish (NFE)
AF:
AC:
453
AN:
1111080
Other (OTH)
AF:
AC:
91
AN:
60314
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
83
166
249
332
415
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
34
68
102
136
170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00563 AC: 858AN: 152368Hom.: 8 Cov.: 34 AF XY: 0.00553 AC XY: 412AN XY: 74506 show subpopulations
GnomAD4 genome
AF:
AC:
858
AN:
152368
Hom.:
Cov.:
34
AF XY:
AC XY:
412
AN XY:
74506
show subpopulations
African (AFR)
AF:
AC:
799
AN:
41592
American (AMR)
AF:
AC:
32
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3472
East Asian (EAS)
AF:
AC:
0
AN:
5178
South Asian (SAS)
AF:
AC:
1
AN:
4834
European-Finnish (FIN)
AF:
AC:
0
AN:
10630
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
18
AN:
68034
Other (OTH)
AF:
AC:
8
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
43
87
130
174
217
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
8
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jan 22, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:1
Sep 30, 2015
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.